Table 3.
Bivariate and multivariate logistic regression analyses of the active surveillance patients with various independent variables and high FoR as the dependent variable and low FoR as the reference.
| Variables | Bivariate analyses |
Multivariable analysis |
||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p value | OR | 95% CI | p value | |
| Age at survey | 0.89 | 0.81–0.98 | 0.019 | 0.89 | 0.80–0.98 | 0.025 |
| Body mass index =25 kg/m2 | 0.54 | 0.23–1.24 | 0.15 | |||
| PSA at diagnosis =10 µg/l | 0.53 | 0.13–2.08 | 0.36 | |||
| Gleason score at biopsy =7a | 1.56 | 0.68–3.28 | 0.32 | |||
| Intermediate EAU risk group | 1.34 | 0.59–3.01 | 0.49 | 1.01 | 0.38–2.66 | 0.99 |
| Self-rated health | 0.95 | 0.91–0.98 | 0.002 | 0.96 | 0.93–1.01 | 0.08 |
| Incontinence score | 0.97 | 0.94–1.00 | 0.049 | 0.98 | 0.95–1.02 | 0.42 |
| Sexual domain score | 0.99 | 0.97–1.01 | 0.24 | |||
| Total fatigue score | 1.25 | 1.08–1.45 | 0.003 | 1.12 | 0.95–1.32 | 0.19 |
| Current sleep problems | 2.81 | 1.15–6.91 | 0.024 | 1.66 | 0.55–5.01 | 0.37 |
| Hazardous alcohol consumption | 2.14 | 0.71–6.45 | 0.18 | |||
| Type D personality | 5.42 | 0.34–21.86 | 0.018 | 2.02 | 0.38–10.77 | 0.41 |
CI = confidence interval; EUA = European Association of Urology; FoR = fear of recurrence; OR = odds ratio; PSA = prostate-specific antigen.